Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 2526 · · 10 pages · English
Hangzhou Diagens Biotechnology Co., Ltd. on 6ix
Earlier from Hangzhou Diagens Biotechnology
- Poll results of the 2026 second extraordinary general meeting held on September 30, 2026
- Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
Later from Hangzhou Diagens Biotechnology
- Change of company logo
- Grant of options and restricted share units under the 2026 share incentive scheme
Follow Hangzhou Diagens Biotechnology into a list and get an email when it puts out news.
Follow Hangzhou Diagens Biotechnology